Press Release Source: The American Stock Exchange
American Stock Exchange Lists Common Stock of Calypte Biomedical Corporation
Wednesday August 18, 9:45 am ET
NEW YORK, Aug. 18 /PRNewswire/ -- The American Stock Exchange® (Amex®) today listed the common stock of Calypte Biomedical Corporation under the ticker symbol HIV.
Calypte Biomedical Corporation, headquartered in Pleasanton, California, is a public healthcare company dedicated to the development and commercialization of in vitro diagnostic tests, primarily for the detection of antibodies to Human Immunodeficiency Virus (HIV), and other sexually transmitted and infectious diseases. Calypte's currently marketed laboratory- based tests include an enzyme immunoassay (EIA) HIV-1 antibody screening test and an HIV-1 antibody western blot supplemental test, the only two FDA- approved HIV-1 antibody tests for use on urine samples, as well as an FDA- approved serum HIV-1 antibody western blot supplemental test.
"We are pleased to welcome Calypte Biomedical to the American Stock Exchange," said John McGonegal, senior vice president of the Amex Equities Group. "We look forward to working with a innovator such as Calypte and providing them with the solid support and services that are essential in today's competitive marketplace."
Anthony Cataldo, Chairman of Calypte commented, "Calypte recently reached a significant milestone when it introduced its rapid urine, blood and saliva HIV screening tests to the world at the 15th International AIDS conference in Bangkok, Thailand. Today's listing on the Amex marks yet another major milestone by providing us support and access to a national exchange as we continue to launch our vital product lines."
The specialist in Calypte Biomedical Corporation will be the Weiskopf, Silver & Co. For further information on HIV and other Amex-listed companies, please visit www.amex.com.
The American Stock Exchange® (Amex®) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 138 ETFs. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit www.amex.com.
--------------------------------------------------
Source: The American Stock Exchange
Zurück
Weiter
Gruß BarCode 
